IFNG and neoplasm: Although tumor antigen-stimulated CD4+ T cells can produce IFN-γ (Th1) or IL-4 (Th2) and both these cytokines can recruit other tumoricidal cells to the tumor site [8, 9, 22], tumor rejection is mediated by IL-4 [10].